Literature DB >> 28365753

Benefit incidence analysis of healthcare in Bangladesh - equity matters for universal health coverage.

Jahangir A M Khan1,2,3,4, Sayem Ahmed2,3,4, Mary MacLennan5, Abdur Razzaque Sarker1,6, Marufa Sultana2, Hafizur Rahman7.   

Abstract

BACKGROUND: Equity in access to and utilization of healthcare is an important goal for any health system and an essential prerequisite for achieving Universal Health Coverage for any country.
OBJECTIVES: This study investigated the extent to which health benefits are distributed across socioeconomic groups; and how different types of providers contribute to inequity in health benefits of Bangladesh.
METHODOLOGY: The distribution of health benefits across socioeconomic groups was estimated using concentration indices. Health benefits from three types of formal providers were analysed (public, private and NGO providers), separated into rural and urban populations. Decomposition of concentration indices into types of providers quantified the relative contribution of providers to the overall distribution of benefits across socioeconomic groups. Eventually, the distribution of benefits was compared to the distribution of healthcare need (proxied by 'self-reported illness and symptoms') across socioeconomic groups. Data from the latest Household Income and Expenditure Survey, 2010 and WHO-CHOICE were used.
RESULTS: An overall pro-rich distribution of healthcare benefits was observed (CI = 0.229, t -value = 9.50). Healthcare benefits from private providers (CI = 0.237, t -value = 9.44) largely favoured the richer socioeconomic groups. Little evidence of inequity in benefits was found in public (CI = 0.044, t -value = 2.98) and NGO (CI = 0.095, t -value = 0.54) providers. Private providers contributed by 95.9% to overall inequity. The poorest socioeconomic group with 21.8% of the need for healthcare received only 12.7% of the benefits, while the richest group with 18.0% of the need accounted for 32.8% of the health benefits.
CONCLUSION: Overall healthcare benefits in Bangladesh were pro-rich, particularly because of health benefits from private providers. Public providers were observed to contribute relatively slightly to inequity. The poorest (richest) people with largest (least) need for healthcare actually received lower (higher) benefits. When working to achieve Universal Health Coverage in Bangladesh, particular consideration should be given to ensuring that private sector care is more equitable.
© The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Concentration indices; decomposition; equity in health benefits; universal health coverage; urban and rural settings

Mesh:

Year:  2017        PMID: 28365753     DOI: 10.1093/heapol/czw131

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  13 in total

1.  Socio-economic inequalities in diabetes and prediabetes among Bangladeshi adults.

Authors:  Abdur Razzaque Sarker; Moriam Khanam
Journal:  Diabetol Int       Date:  2021-10-25

2.  The effect of a community-based health insurance on the out-of-pocket payments for utilizing medically trained providers in Bangladesh.

Authors:  Jahangir A M Khan; Sayem Ahmed; Marufa Sultana; Abdur Razzaque Sarker; Sanchita Chakrovorty; Mohammad Hafizur Rahman; Ziaul Islam; Clas Rehnberg; Louis W Niessen
Journal:  Int Health       Date:  2020-07-01       Impact factor: 2.473

3.  Effectiveness of health voucher scheme and micro-health insurance scheme to support the poor and extreme poor in selected urban areas of Bangladesh: An assessment using a mixed-method approach.

Authors:  Sayem Ahmed; Md Zahid Hasan; Nausad Ali; Mohammad Wahid Ahmed; Emranul Haq; Sadia Shabnam; Morseda Chowdhury; Breda Gahan; Christine Bousquet; Jahangir A M Khan; Ziaul Islam
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

4.  Technical efficiency of public district hospitals in Bangladesh: a data envelopment analysis.

Authors:  Sayem Ahmed; Md Zahid Hasan; Samia Laokri; Zerin Jannat; Mohammad Wahid Ahmed; Farzana Dorin; Veronica Vargas; Jahangir A M Khan
Journal:  Cost Eff Resour Alloc       Date:  2019-07-24

5.  Universal Health Coverage in Bangladesh: Activities, Challenges, and Suggestions.

Authors:  Taufique Joarder; Tahrim Z Chaudhury; Ishtiaq Mannan
Journal:  Psyche (Camb Mass)       Date:  2019-03-03

6.  Did the poor gain from India's health policy interventions? Evidence from benefit-incidence analysis, 2004-2018.

Authors:  Sakthivel Selvaraj; Anup K Karan; Wenhui Mao; Habib Hasan; Ipchita Bharali; Preeti Kumar; Osondu Ogbuoji; Chetana Chaudhuri
Journal:  Int J Equity Health       Date:  2021-07-10

7.  Estimating benefit equity of government health subsidy in healthcare Services in Shandong Province, China: a cross-sectional study.

Authors:  Wenzhe Qin; Lingzhong Xu; Jiajia Li; Long Sun; Gan Ding; Hui Shao; Ningze Xu
Journal:  Int J Equity Health       Date:  2018-05-18

8.  Socioeconomic Inequalities of Undiagnosed Diabetes in a Resource-Poor Setting: Insights from the Cross-Sectional Bangladesh Demographic and Health Survey 2011.

Authors:  Md Mehedi Hasan; Fariha Tasnim; Md Tariqujjaman; Sayem Ahmed
Journal:  Int J Environ Res Public Health       Date:  2019-01-03       Impact factor: 3.390

9.  Reduction in inequalities in health insurance coverage and healthcare utilization among older adults in the Philippines after mandatory national health insurance coverage: trend analysis for 2003-2017.

Authors:  Kathryn Lizbeth Lucena Siongco; Keiko Nakamura; Kaoruko Seino
Journal:  Environ Health Prev Med       Date:  2020-06-09       Impact factor: 3.674

10.  Healthcare seeking for chronic illness among adult slum dwellers in Bangladesh: A descriptive cross-sectional study in two urban settings.

Authors:  Alayne M Adams; Rubana Islam; Sifat Shahana Yusuf; Anthony Panasci; Nancy Crowell
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.